Effects of doxycycline on intestinal ischemia reperfusion injury induced by abdominal compartment syndrome in a rat model

Current Therapeutic Research - Clinical and Experimental

Volumn 71, Issue 3, 2010, Pages 186-198

  Fatih Yasar N ^a   Özdemir, Riza ^a   Ihtiyar, Enver ^a   Erkasap, Nilüfer ^a   Köken, Tülay ^b   Tosun, Murat ^b   Öner, Setenay ^a   Erkasap, Serdar ^a  

^a OSMANGAZI UNIVERSITY MEDICAL FACULTY   (Turkey)

^b AFYON KOCATEPE UNIVERSITY   (Turkey)

Author keywords

Abdominal compartment syndrome; Apoptosis; Doxycycline; Intestinal ischemia reperfusion injury

Indexed keywords

DOXYCYCLINE; GELATINASE A; INTERLEUKIN 1BETA; INTERLEUKIN 6; MALONALDEHYDE; PROTEIN BCL 2; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL COMPARTMENT SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; B CELL LYMPHOMA; CONTROLLED STUDY; DRUG EFFECT; FEMALE; INTESTINE ISCHEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY;

EID: 77954755532     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.curtheres.2010.06.004     Document Type: Article

References (35)

1. Saggi BH, Sugerman HJ, Ivatury RR, Bloomfield GL Abdominal compartment syndrome. J Trauma. 1998, 45:597-609.
2. Diebel LN, Dulchavsky SA, Wilson RF Effect of increased intra-abdominal pressure on mes-enteric arterial and intestinal mucosal blood flow. J Trauma. 1992, 33:45-49.
3. Kimball EJ Intra-abdominal hypertension and the abdominal compartment syndrome: 'ARDS' of the gut. Int J Intensive Care. 2006, 1:31-39.
4. Rezende-Neto JB, Moore EE, Melo de Andrade MV, et al. Systemic inflammatory response secondary to abdominal compartment syndrome: Stage for multiple organ failure. J Trauma. 2002, 53:1121-1128.
5. Kaçmaz A, Polat A, User Y, et al. Octreotide: A new approach to the management of acute abdominal hypertension. Peptides. 2003, 24:1381-1386.
6. Eleftheriadis E, Kotzampassi K, Papanotas K, et al. Gut ischemia, oxidative stress, and bacterial translocation in elevated abdominal pressure in rats. World J Surg. 1996, 20:11-16.
7. Werns SW, Lucchesi BR Free radical and ischemic tissue injury. Trends Pharmacol Sci. 1990, 11:161-166.
8. Kienle K, Rentsch M, Müller T, et al. Expression of BCL-2 in liver grafts after adenoviral transfer improves survival following prolonged ischemia and reperfusion in rat liver transplantation. Transplant Proc. 2005, 37:439-441.
9. Shirahane K, Yamaguchi K, Koga K, et al. Hepatic ischemia/reperfusion injury is prevented by a novel matrix metalloproteinase inhibitor, ONO-4817. Surgery. 2006, 139:653-664.
10. Caron A, Desrosiers RR, Langlois S, Béliveau R Ischemia-reperfusion injury stimulates gelatinase expression and activity in kidney glomeruli. Can J Physiol Pharmacol. 2005, 83:287-300.
11. Rosário HS, Waldo SW, Becker SA, Schmid-Schönbein GW Pancreatic trypsin increases matrix metalloproteinase-9 accumulation and activation during acute intestinal ischemia-reperfusion in the rat. Am J Pathol. 2004, 164:1707-1716.
12. Souza DG, Ferreira FL, Fagundes CT, et al. Effects of PKF242-484 and PKF241-466, novel dual inhibitors of TNF-alpha converting enzyme and matrix metalloproteinases, in a model of intestinal reperfusion injury in mice. Eur J Pharmacol. 2007, 571:72-80.
13. Vaday GG, Hershkoviz R, Rahat MA, et al. Fibronectin-bound TNF-alpha stimulates mono-cyte matrix metalloproteinase-9 expression and regulates chemotaxis. J Leukoc Biol. 2000, 68:737-747.
14. Sethi C, Bailey T, Luthert P, Chong N Matrix metalloproteinase biology applied to vitreoretinal disorders. Br J Ophthalmol. 2000, 84:654-666.
15. Schönbeck U, Mach F, Libby P Generation of biologically active IL-1 beta by matrix metalloproteinases: A novel caspase-1-independent pathway of IL-1 beta processing. J Immunol. 1998, 161:3340-3346.
16. Gueders MM, Bertholet P, Perin F, et al. A novel formulation of inhaled doxycycline reduces allergen-induced inflammation, hyperresponsiveness and remodeling by matrix metalloprotei-nases and cytokines modulation in a mouse model of asthma. Biochem Pharmacol. 2008, 75:514-526.
17. Shen J, O'Brien D, Xu Y Matrix metalloproteinase-2 contributes to tumor necrosis factor alpha induced apoptosis in cultured rat cardiac myocytes. Biochem Biophys Res Commun. 2006, 347:1011-1020.
18. De Paiva CS, Corrales RM, Villarreal AL, et al. Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye. Exp Eye Res. 2006, 83:526-535.
19. Yao JS, Shen F, Young WL, Yang GY Comparison of doxycycline and minocycline in the inhibition of VEGF-induced smooth muscle cell migration. Neurochem Int. 2007, 50:524-530.
20. Yeh YC, Lai HC, Ting CT, et al. Protection by doxycycline against doxorubicin-induced oxi-dative stress and apoptosis in mouse testes. Biochem Pharmacol. 2007, 74:969-980.
21. Valdés F, Pásaro E, Diazi I, et al. Segmental heterogeneity in Bcl-2, Bcl-xL and Bax expression in rat tubular epithelium after ischemia-reperfusion. Nephrology (Carlton). 2008, 13:294-301.
22. Kelly KJ, Sutton TA, Weathered N, et al. Minocycline inhibits apoptosis and inflammation in a rat model of ischemic renal injury. Am J Physiol Renal Physiol. 2004, 287:F760-F766.
23. Wang J, Wei Q, Wang CY, et al. Minocycline up-regulates Bcl-2 and protects against cell death in mitochondria. J Biol Chem. 2004, 279:19948-19954.
24. Smith JR, Gabler WL Protective effects of doxycycline in mesenteric ischemia and reperfusion. Res Commun Mol Pathol Pharmacol. 1995, 88:303-315.
25. Unsal MA, Imamoglu M, Kadioglu M, et al. The acute alterations in biochemistry, morphology, and contractility of rat-isolated terminal ileum via increased intra-abdominal pressure. Pharmacol Res. 2006, 53:135-141.
26. Spanos CP, Papaconstantinou P, Spanos P, et al. The effect of L-arginine and aprotinin on intestinal ischemia-reperfusion injury. J Gastrointest Surg. 2007, 11:247-255.
27. Di Paola R, Menegazzi M, Mazzon E, et al. Protective effects of glycyrrhizin in a gut hypoxia (ischemia)-reoxygenation (reperfusion) model. Intensive Care Med. 2009, 35:687-697.
28. Cazalis J, Bodet C, Gagnon G, Greiner D Doxycycline reduces lipopolysaccharide-induced inflammatory mediator secretion in macrophage and ex vivo human blood models. J Peridontol. 2008, 79:1762-1768.
29. De Paiva CS, Corrales RM, Villarreal AL, et al. Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye. Biochem Biophys Res Commun. 2006, 347:1011-1020.
30. Kirkwood K, Martin T, Andreas ST, Kim YJ Chemically modified tetracyclines selectively inhibit IL-6 expression in osteoblasts by decreasing mRNA stability. Transplant. 2008, 17:223-229.
31. Robinson EK, Kelly DP, Mercer DW, Kozar RA Differential effects of luminal arginine and glutamine on metalloproteinase production in the postischemic gut. JPEN J Parenter Enteral Nutr. 2008, 32:433-438.
32. Saito K, Mori S, Tanda N, Sakamoto S Expression of p53 protein and Ki-67 Antigen in gingival hyperplasia induced by nifedipine and phenytoin. J Periodontol. 1999, 70:581-586.
33. Chen W, Fu XB, Ge SL, et al. Intravenous acid fibroblast growth factor protects intestinal mucosal cells against ischemia-reperfusion injury via regulating Bcl-2/Bax expression. World J Gastroenterol. 2005, 11:3419-3425.
34. Liu KX, Wu WK, He W, Sun HL Study on sini decoction in treatment of intestinal ischemia-reperfusion injury in rats: Mechanism relating to oxygen radical and bcl-2 protein [in Chinese]. Zhongguo Zhong Yao Za Zhi. 2006, 31:329-332.
35. Liu KX, Wu WK, He W, Sun HL Study on sini decoction in treatment of intestinal ischemia-reperfusion injury in rats: Mechanism relating to oxygen radical and bcl-2 protein [in Chinese]. Zhongguo Zhong Yao Za Zhi. 2006, 31:348.